Differential Activation of Monocytes in Haemodialysis Patients Exposed to Different Types of Membranes

Peripheral blood mononuclear cells (PBMC) from haemodialysis patients treated with different types of membranes were isolated, incubated in vitro, and extracellular and cell‐associated interleukin 1 (IL‐1) assayed by radioimmunological methods. Extracellular IL‐1 was low and not different from contr...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Scandinavian journal of immunology 1990-02, Vol.31 (2), p.183-190
Hauptverfasser: BLUMENSTEIN, M., ZIEGLER‐HEITBROCK, H. W. L., SCHILLER, B., SCHMIDT, B., WARD, R. A., GURLAND, H. J.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 190
container_issue 2
container_start_page 183
container_title Scandinavian journal of immunology
container_volume 31
creator BLUMENSTEIN, M.
ZIEGLER‐HEITBROCK, H. W. L.
SCHILLER, B.
SCHMIDT, B.
WARD, R. A.
GURLAND, H. J.
description Peripheral blood mononuclear cells (PBMC) from haemodialysis patients treated with different types of membranes were isolated, incubated in vitro, and extracellular and cell‐associated interleukin 1 (IL‐1) assayed by radioimmunological methods. Extracellular IL‐1 was low and not different from controls, regardless of the dialyser used. In contrast, cell‐associated IL‐1 was increased in patients treated with dialysers containing low‐Hux Cuprophan (CU, n = 5) and polyacrylonitrile sheet membrane (AN69, n = 5), Patients treated with diaiysers containing highflux polysulphone (PS, n= 7), and polymethylmethacrylate (PMMA, n= S), exhibited no increase in cell‐associated IL‐l under these conditions. To elucidate the mechanism of the activation, aqueous extracts of dialysers containing CU, PS, and AN69 were tested for their ability to induce IL‐1 generation in PBMC from healthy donors. Extracts from unrinsed CU‐containing dialysers caused significant IL‐1 synthesis and release, whereas incubation with extracts from dialysers containing PS and AN69 sheet membranes did not. Hence, although both CU and AN69 sheet type dialysers result in activation of blood monocytes the mechanism of action appears to be different. We speculate that functional signs of PBMC activation as evidenced by increased spontaneous IL‐1 production observed in some patients on long‐term haemodialysis may result from extractable dialyser membrane material while in other instances direct cell membrane interactions or endotoxin transfer from the dialysate may be relevant.
doi_str_mv 10.1111/j.1365-3083.1990.tb02758.x
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_79661478</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>79661478</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3443-4e38ce7652568b6e944f5ebc71fffdb09aab36c0bedb030282142e0c855fd14c3</originalsourceid><addsrcrecordid>eNqVkVGL1DAUhYMo67j6E4Qg4lu7N02aNj4Iy7q6K7us4Poc0vQGMrTN2HTW6b83Zcq8yuYlhPOdk8u5hHxgkLN0LrY547LMONQ8Z0pBPjVQVGWdH16QzUl6STbAATIlqvI1eRPjFoDxouJn5KzgoBiwDXFfvXM44jB509FLO_knM_kw0ODofRiCnSeM1A_0xmAf2gTN0Uf6M0HJE-n1YRcitnQK9JREH-ddMi0J2DejGTC-Ja-c6SK-W-9z8vvb9ePVTXb38P326vIus1wIngnktcVKlkUp60aiEsKV2NiKOefaBpQxDZcWGkwPDkVdMFEg2LosXcuE5efk0zF3N4Y_e4yT7n202HVpiLCPulJSMlHV_wVZGoCVsICfj6AdQ4wjOr0bfW_GWTPQyzb0Vi-V66VyvWxDr9vQh2R-v_6yb3psT9a1_qR_XHUTrelc6sr6eMKkAlmpBftyxP76DudnDKB__bhlNef_AP7sp-0</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>15681508</pqid></control><display><type>article</type><title>Differential Activation of Monocytes in Haemodialysis Patients Exposed to Different Types of Membranes</title><source>MEDLINE</source><source>Wiley Online Library Journals Frontfile Complete</source><creator>BLUMENSTEIN, M. ; ZIEGLER‐HEITBROCK, H. W. L. ; SCHILLER, B. ; SCHMIDT, B. ; WARD, R. A. ; GURLAND, H. J.</creator><creatorcontrib>BLUMENSTEIN, M. ; ZIEGLER‐HEITBROCK, H. W. L. ; SCHILLER, B. ; SCHMIDT, B. ; WARD, R. A. ; GURLAND, H. J.</creatorcontrib><description>Peripheral blood mononuclear cells (PBMC) from haemodialysis patients treated with different types of membranes were isolated, incubated in vitro, and extracellular and cell‐associated interleukin 1 (IL‐1) assayed by radioimmunological methods. Extracellular IL‐1 was low and not different from controls, regardless of the dialyser used. In contrast, cell‐associated IL‐1 was increased in patients treated with dialysers containing low‐Hux Cuprophan (CU, n = 5) and polyacrylonitrile sheet membrane (AN69, n = 5), Patients treated with diaiysers containing highflux polysulphone (PS, n= 7), and polymethylmethacrylate (PMMA, n= S), exhibited no increase in cell‐associated IL‐l under these conditions. To elucidate the mechanism of the activation, aqueous extracts of dialysers containing CU, PS, and AN69 were tested for their ability to induce IL‐1 generation in PBMC from healthy donors. Extracts from unrinsed CU‐containing dialysers caused significant IL‐1 synthesis and release, whereas incubation with extracts from dialysers containing PS and AN69 sheet membranes did not. Hence, although both CU and AN69 sheet type dialysers result in activation of blood monocytes the mechanism of action appears to be different. We speculate that functional signs of PBMC activation as evidenced by increased spontaneous IL‐1 production observed in some patients on long‐term haemodialysis may result from extractable dialyser membrane material while in other instances direct cell membrane interactions or endotoxin transfer from the dialysate may be relevant.</description><identifier>ISSN: 0300-9475</identifier><identifier>EISSN: 1365-3083</identifier><identifier>DOI: 10.1111/j.1365-3083.1990.tb02758.x</identifier><identifier>PMID: 2309101</identifier><identifier>CODEN: SJIMAX</identifier><language>eng</language><publisher>Oxford, UK: Blackwell Publishing Ltd</publisher><subject>Adult ; Aged ; Analysis of Variance ; Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy ; Biological and medical sciences ; Emergency and intensive care: renal failure. Dialysis management ; Female ; Humans ; Intensive care medicine ; Interleukin-1 - biosynthesis ; Kidney Failure, Chronic - immunology ; Kidney Failure, Chronic - therapy ; Leukocyte Count ; Leukocytes, Mononuclear - immunology ; Leukocytes, Mononuclear - metabolism ; Lipopolysaccharides - metabolism ; Lymphocyte Activation - immunology ; Male ; Medical sciences ; Membranes, Artificial ; Middle Aged ; Renal Dialysis - adverse effects</subject><ispartof>Scandinavian journal of immunology, 1990-02, Vol.31 (2), p.183-190</ispartof><rights>1990 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3443-4e38ce7652568b6e944f5ebc71fffdb09aab36c0bedb030282142e0c855fd14c3</citedby><cites>FETCH-LOGICAL-c3443-4e38ce7652568b6e944f5ebc71fffdb09aab36c0bedb030282142e0c855fd14c3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1111%2Fj.1365-3083.1990.tb02758.x$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1111%2Fj.1365-3083.1990.tb02758.x$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,780,784,1416,27915,27916,45565,45566</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=6906791$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/2309101$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>BLUMENSTEIN, M.</creatorcontrib><creatorcontrib>ZIEGLER‐HEITBROCK, H. W. L.</creatorcontrib><creatorcontrib>SCHILLER, B.</creatorcontrib><creatorcontrib>SCHMIDT, B.</creatorcontrib><creatorcontrib>WARD, R. A.</creatorcontrib><creatorcontrib>GURLAND, H. J.</creatorcontrib><title>Differential Activation of Monocytes in Haemodialysis Patients Exposed to Different Types of Membranes</title><title>Scandinavian journal of immunology</title><addtitle>Scand J Immunol</addtitle><description>Peripheral blood mononuclear cells (PBMC) from haemodialysis patients treated with different types of membranes were isolated, incubated in vitro, and extracellular and cell‐associated interleukin 1 (IL‐1) assayed by radioimmunological methods. Extracellular IL‐1 was low and not different from controls, regardless of the dialyser used. In contrast, cell‐associated IL‐1 was increased in patients treated with dialysers containing low‐Hux Cuprophan (CU, n = 5) and polyacrylonitrile sheet membrane (AN69, n = 5), Patients treated with diaiysers containing highflux polysulphone (PS, n= 7), and polymethylmethacrylate (PMMA, n= S), exhibited no increase in cell‐associated IL‐l under these conditions. To elucidate the mechanism of the activation, aqueous extracts of dialysers containing CU, PS, and AN69 were tested for their ability to induce IL‐1 generation in PBMC from healthy donors. Extracts from unrinsed CU‐containing dialysers caused significant IL‐1 synthesis and release, whereas incubation with extracts from dialysers containing PS and AN69 sheet membranes did not. Hence, although both CU and AN69 sheet type dialysers result in activation of blood monocytes the mechanism of action appears to be different. We speculate that functional signs of PBMC activation as evidenced by increased spontaneous IL‐1 production observed in some patients on long‐term haemodialysis may result from extractable dialyser membrane material while in other instances direct cell membrane interactions or endotoxin transfer from the dialysate may be relevant.</description><subject>Adult</subject><subject>Aged</subject><subject>Analysis of Variance</subject><subject>Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy</subject><subject>Biological and medical sciences</subject><subject>Emergency and intensive care: renal failure. Dialysis management</subject><subject>Female</subject><subject>Humans</subject><subject>Intensive care medicine</subject><subject>Interleukin-1 - biosynthesis</subject><subject>Kidney Failure, Chronic - immunology</subject><subject>Kidney Failure, Chronic - therapy</subject><subject>Leukocyte Count</subject><subject>Leukocytes, Mononuclear - immunology</subject><subject>Leukocytes, Mononuclear - metabolism</subject><subject>Lipopolysaccharides - metabolism</subject><subject>Lymphocyte Activation - immunology</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Membranes, Artificial</subject><subject>Middle Aged</subject><subject>Renal Dialysis - adverse effects</subject><issn>0300-9475</issn><issn>1365-3083</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1990</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqVkVGL1DAUhYMo67j6E4Qg4lu7N02aNj4Iy7q6K7us4Poc0vQGMrTN2HTW6b83Zcq8yuYlhPOdk8u5hHxgkLN0LrY547LMONQ8Z0pBPjVQVGWdH16QzUl6STbAATIlqvI1eRPjFoDxouJn5KzgoBiwDXFfvXM44jB509FLO_knM_kw0ODofRiCnSeM1A_0xmAf2gTN0Uf6M0HJE-n1YRcitnQK9JREH-ddMi0J2DejGTC-Ja-c6SK-W-9z8vvb9ePVTXb38P326vIus1wIngnktcVKlkUp60aiEsKV2NiKOefaBpQxDZcWGkwPDkVdMFEg2LosXcuE5efk0zF3N4Y_e4yT7n202HVpiLCPulJSMlHV_wVZGoCVsICfj6AdQ4wjOr0bfW_GWTPQyzb0Vi-V66VyvWxDr9vQh2R-v_6yb3psT9a1_qR_XHUTrelc6sr6eMKkAlmpBftyxP76DudnDKB__bhlNef_AP7sp-0</recordid><startdate>199002</startdate><enddate>199002</enddate><creator>BLUMENSTEIN, M.</creator><creator>ZIEGLER‐HEITBROCK, H. W. L.</creator><creator>SCHILLER, B.</creator><creator>SCHMIDT, B.</creator><creator>WARD, R. A.</creator><creator>GURLAND, H. J.</creator><general>Blackwell Publishing Ltd</general><general>Blackwell</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7T5</scope><scope>H94</scope><scope>7X8</scope></search><sort><creationdate>199002</creationdate><title>Differential Activation of Monocytes in Haemodialysis Patients Exposed to Different Types of Membranes</title><author>BLUMENSTEIN, M. ; ZIEGLER‐HEITBROCK, H. W. L. ; SCHILLER, B. ; SCHMIDT, B. ; WARD, R. A. ; GURLAND, H. J.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3443-4e38ce7652568b6e944f5ebc71fffdb09aab36c0bedb030282142e0c855fd14c3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1990</creationdate><topic>Adult</topic><topic>Aged</topic><topic>Analysis of Variance</topic><topic>Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy</topic><topic>Biological and medical sciences</topic><topic>Emergency and intensive care: renal failure. Dialysis management</topic><topic>Female</topic><topic>Humans</topic><topic>Intensive care medicine</topic><topic>Interleukin-1 - biosynthesis</topic><topic>Kidney Failure, Chronic - immunology</topic><topic>Kidney Failure, Chronic - therapy</topic><topic>Leukocyte Count</topic><topic>Leukocytes, Mononuclear - immunology</topic><topic>Leukocytes, Mononuclear - metabolism</topic><topic>Lipopolysaccharides - metabolism</topic><topic>Lymphocyte Activation - immunology</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Membranes, Artificial</topic><topic>Middle Aged</topic><topic>Renal Dialysis - adverse effects</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>BLUMENSTEIN, M.</creatorcontrib><creatorcontrib>ZIEGLER‐HEITBROCK, H. W. L.</creatorcontrib><creatorcontrib>SCHILLER, B.</creatorcontrib><creatorcontrib>SCHMIDT, B.</creatorcontrib><creatorcontrib>WARD, R. A.</creatorcontrib><creatorcontrib>GURLAND, H. J.</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Immunology Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Scandinavian journal of immunology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>BLUMENSTEIN, M.</au><au>ZIEGLER‐HEITBROCK, H. W. L.</au><au>SCHILLER, B.</au><au>SCHMIDT, B.</au><au>WARD, R. A.</au><au>GURLAND, H. J.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Differential Activation of Monocytes in Haemodialysis Patients Exposed to Different Types of Membranes</atitle><jtitle>Scandinavian journal of immunology</jtitle><addtitle>Scand J Immunol</addtitle><date>1990-02</date><risdate>1990</risdate><volume>31</volume><issue>2</issue><spage>183</spage><epage>190</epage><pages>183-190</pages><issn>0300-9475</issn><eissn>1365-3083</eissn><coden>SJIMAX</coden><abstract>Peripheral blood mononuclear cells (PBMC) from haemodialysis patients treated with different types of membranes were isolated, incubated in vitro, and extracellular and cell‐associated interleukin 1 (IL‐1) assayed by radioimmunological methods. Extracellular IL‐1 was low and not different from controls, regardless of the dialyser used. In contrast, cell‐associated IL‐1 was increased in patients treated with dialysers containing low‐Hux Cuprophan (CU, n = 5) and polyacrylonitrile sheet membrane (AN69, n = 5), Patients treated with diaiysers containing highflux polysulphone (PS, n= 7), and polymethylmethacrylate (PMMA, n= S), exhibited no increase in cell‐associated IL‐l under these conditions. To elucidate the mechanism of the activation, aqueous extracts of dialysers containing CU, PS, and AN69 were tested for their ability to induce IL‐1 generation in PBMC from healthy donors. Extracts from unrinsed CU‐containing dialysers caused significant IL‐1 synthesis and release, whereas incubation with extracts from dialysers containing PS and AN69 sheet membranes did not. Hence, although both CU and AN69 sheet type dialysers result in activation of blood monocytes the mechanism of action appears to be different. We speculate that functional signs of PBMC activation as evidenced by increased spontaneous IL‐1 production observed in some patients on long‐term haemodialysis may result from extractable dialyser membrane material while in other instances direct cell membrane interactions or endotoxin transfer from the dialysate may be relevant.</abstract><cop>Oxford, UK</cop><pub>Blackwell Publishing Ltd</pub><pmid>2309101</pmid><doi>10.1111/j.1365-3083.1990.tb02758.x</doi><tpages>8</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0300-9475
ispartof Scandinavian journal of immunology, 1990-02, Vol.31 (2), p.183-190
issn 0300-9475
1365-3083
language eng
recordid cdi_proquest_miscellaneous_79661478
source MEDLINE; Wiley Online Library Journals Frontfile Complete
subjects Adult
Aged
Analysis of Variance
Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy
Biological and medical sciences
Emergency and intensive care: renal failure. Dialysis management
Female
Humans
Intensive care medicine
Interleukin-1 - biosynthesis
Kidney Failure, Chronic - immunology
Kidney Failure, Chronic - therapy
Leukocyte Count
Leukocytes, Mononuclear - immunology
Leukocytes, Mononuclear - metabolism
Lipopolysaccharides - metabolism
Lymphocyte Activation - immunology
Male
Medical sciences
Membranes, Artificial
Middle Aged
Renal Dialysis - adverse effects
title Differential Activation of Monocytes in Haemodialysis Patients Exposed to Different Types of Membranes
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-15T05%3A44%3A06IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Differential%20Activation%20of%20Monocytes%20in%20Haemodialysis%20Patients%20Exposed%20to%20Different%20Types%20of%20Membranes&rft.jtitle=Scandinavian%20journal%20of%20immunology&rft.au=BLUMENSTEIN,%20M.&rft.date=1990-02&rft.volume=31&rft.issue=2&rft.spage=183&rft.epage=190&rft.pages=183-190&rft.issn=0300-9475&rft.eissn=1365-3083&rft.coden=SJIMAX&rft_id=info:doi/10.1111/j.1365-3083.1990.tb02758.x&rft_dat=%3Cproquest_cross%3E79661478%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=15681508&rft_id=info:pmid/2309101&rfr_iscdi=true